Rein Therapeutics, Inc. (RNTX) AI Dilution Summary

Cash was $40,647,000 at the 2026-06-30 balance-sheet date, against estimated monthly burn of $2,010,667. That figure already includes the $57,500,000 gross public offering that closed 2026-05-04, in which 57,500,000 shares were sold at $1.00. The most recent capital raised was ATM sales through 2026-06-30 with H.C. Wainwright & Co., LLC, under a program authorised to $8,066,607.